Agenus Inc. (AGEN) has disclosed a new risk, in the Regulation category.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Agenus Inc.’s operational results and financial health remain vulnerable to a variety of risks and uncertainties, as outlined in their Annual Report on Form 10-K for the fiscal year ending December 31, 2024. Despite the passage of time, there have been no significant changes to the risk factors previously identified in Part I, Item 1A of the 2024 Form 10-K. This ongoing exposure to potential risks could impact the company’s performance and investor confidence. Stakeholders should remain vigilant about these persistent uncertainties as they assess the company’s future prospects.
Overall, Wall Street has a Moderate Buy consensus rating on AGEN stock based on 2 Buys and 3 Holds.
To learn more about Agenus Inc.’s risk factors, click here.